The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B (HBV) Vaccine for children and adults included in the National Vaccination Programme in Finland. The contract period is two (2) years during 2027-2029. The procurement contains two (2) one-year (1) contract period renewals (1+1) to extend the contract for 2029-2030 and 2030-2031. Estimated quantity for the contract period including contract period renewals is 200.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. On average THL delivers to wellbeing services counties/municipalities 35.000 +/- 5.000 doses for adults per year and 12.000 +/- 2000 doses for children per year (numbers are only rough estimations to help with allocating doses). The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest total reference price for the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2025 SUPPLIES Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service Annex 6 Bank details Annex 7 Quality Agreement
hankintailmoitus (2026-04-15) Kohde Hankinnan laajuus
Otsikko: Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031)
Viitenumero: THL/1110/2.02.06/2026
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B (HBV) Vaccine for children and adults included in the National Vaccination Programme in Finland.
The contract period is two (2) years during 2027-2029. The procurement contains two (2) one-year (1) contract period renewals (1+1) to extend the contract for 2029-2030 and 2030-2031.
Estimated quantity for the contract period including contract period renewals is 200.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. On average THL delivers to wellbeing services counties/municipalities 35.000 +/- 5.000 doses for adults per year and 12.000 +/- 2000 doses for children per year (numbers are only rough estimations to help with allocating doses).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest total reference price for the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for Tenders, annexes:
Annex 1 Contract
Annex 2 JYSE 2025 SUPPLIES
Annex 3 Delivery schedule
Annex 4 Subcontractors
Annex 5 Description of the Handi Service
Annex 6 Bank details
Annex 7 Quality Agreement
Näytä lisää
Sopimustyyppi: Tavarat
Tuotteet/palvelut: Rokotteet📦 Kuvaus
Hankinnan kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request...”
Hankinnan kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B (HBV) Vaccine for children and adults included in the National Vaccination Programme in Finland.
The contract period is two (2) years during 2027-2029. The procurement contains two (2) one-year (1) contract period renewals (1+1) to extend the contract for 2029-2030 and 2030-2031.
Estimated quantity for the contract period including contract period renewals is 200.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. On average THL delivers to wellbeing services counties/municipalities 35.000 +/- 5.000 doses for adults per year and 12.000 +/- 2000 doses for children per year (numbers are only rough estimations to help with allocating doses).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest total reference price for the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for Tenders, annexes:
Annex 1 Contract
Annex 2 JYSE 2025 SUPPLIES
Annex 3 Delivery schedule
Annex 4 Subcontractors
Annex 5 Description of the Handi Service
Annex 6 Bank details
Annex 7 Quality Agreement
Näytä lisää
Lisätietoja:
“The purpose of STM and the Customer is to procure Hepatitis B (HBV) vaccine required for the National Vaccination Programme in Finland. The tendered...”
Lisätietoja
The purpose of STM and the Customer is to procure Hepatitis B (HBV) vaccine required for the National Vaccination Programme in Finland. The tendered vaccines shall be suitable for adults and children according to Article´s Summary of Product Characteristics (SPC). The Customer should prefer syringes without fixed needles.
This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Dividing the procurement into lots could cause a risk for compatibility problems when there is a difference on age indications for adult and pediatric vaccines from different manufacturers. This could lead to situation where implementation of national immunization programme would be impossible if there would be no product suitable for adolescents whose age is not indicated in neither pediatric formulation or adult formulation. Other reason for not to divide procurement into lots is a need to ensure medication safety when implementing national immunization programme and use of different manufacturers products for adult and pediatric population could increase the risk for medication deviation.
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)
CONTRACT PERIOD
The Contract shall enter into a force once the competent signatories of the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.
However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery lot of the Articles to a Customer’s pharmaceutical wholesaler.
The Contract period is two (2) years from the date defined previously above and the estimated quantity purchased for this period is 100.000 +/- 20 % doses (children and adult doses combined).
After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.
The following procurement concerning Hepatitis B (HBV) Vaccine will take a place in 2030. Please note this is only an estimation and the situation may vary during the upcoming years.
Näytä lisää Myöntämisperusteet
Hinta ✅
Hinta (painotus): 100
Otsikko
Erän tunnistenumero: LOT-0000
Menettely Toimenpiteen tyyppi
Avoin menettely ✅ Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2026-05-18 09:00:00 📅
Tarjousten avaamista koskevat ehdot: 2026-05-18 09:01:00 📅
Tarjousten avaamista koskevat ehdot (paikka): Please note that the opening of tenders is an early estimate date. The opening of the tenders is not a public event. The online connection to the Cloudia Supplier Portal can be periodically slow and the download time will take time. Please fill out the Tenders information in good time before the deadline expires.
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“For further details please see Call for Tenders.”
“The purpose of STM and the Customer is to procure Hepatitis B (HBV) vaccine required for the National Vaccination Programme in Finland. The tendered...”
The purpose of STM and the Customer is to procure Hepatitis B (HBV) vaccine required for the National Vaccination Programme in Finland. The tendered vaccines shall be suitable for adults and children according to Article´s Summary of Product Characteristics (SPC). The Customer should prefer syringes without fixed needles.
This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Dividing the procurement into lots could cause a risk for compatibility problems when there is a difference on age indications for adult and pediatric vaccines from different manufacturers. This could lead to situation where implementation of national immunization programme would be impossible if there would be no product suitable for adolescents whose age is not indicated in neither pediatric formulation or adult formulation. Other reason for not to divide procurement into lots is a need to ensure medication safety when implementing national immunization programme and use of different manufacturers products for adult and pediatric population could increase the risk for medication deviation.
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)
CONTRACT PERIOD
The Contract shall enter into a force once the competent signatories of the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.
However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery lot of the Articles to a Customer’s pharmaceutical wholesaler.
The Contract period is two (2) years from the date defined previously above and the estimated quantity purchased for this period is 100.000 +/- 20 % doses (children and adult doses combined).
After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.
Näytä lisää Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi📧
Puhelin: +358 295643300📞
URL: http://www.oikeus.fi/markkinaoikeus🌏 Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):
“The appeal must be submitted in writing within 14 days of the party receiving the notification of the procurement decision, including the appeal...”
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista)
The appeal must be submitted in writing within 14 days of the party receiving the notification of the procurement decision, including the appeal instructions. The date of receipt of the notification is not included in the appeal period. The appeal must be received on the last day of the appeal period before the end of the Market Court's opening hours.
Näytä lisää Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Sähköistä tilaamista käytetään
Sähköistä maksua käytetään
Lähde: OJS 2026/S 074-259568 (2026-04-15)